H
Herbert Budka
Researcher at University of Zurich
Publications - 417
Citations - 26786
Herbert Budka is an academic researcher from University of Zurich. The author has contributed to research in topics: Neuropathology & PRNP. The author has an hindex of 85, co-authored 412 publications receiving 25100 citations. Previous affiliations of Herbert Budka include Medical University of Vienna & University of Pécs.
Papers
More filters
Journal ArticleDOI
Inflammatory Demyelinating Polyradiculitis in a Patient With Multiple Sclerosis
TL;DR: To the authors' knowledge, this is the first description of simultaneous acute inflammatory demyelination in the CNS and PNS in MS.
Journal ArticleDOI
Neuronal damage in the cerebral cortex of AIDS brains: a morphometric study
Serge Weis,H. Haug,Herbert Budka +2 more
TL;DR: The fronto-orbital cortex, in contrast to the parietal cortex, is mainly damaged in AIDS brains, and was not significantly correlated with development of dementing symptoms and of HIV-specific neuropathology.
Journal ArticleDOI
Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS)
TL;DR: The data do not suggest transactivation of local HIV production by opportunistic agents as a frequent event in vivo, and development of specific HIV histopathology appears correlated with the number of productively infected cells.
Journal ArticleDOI
Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.
Stefan Wolfsberger,Ingeborg Fischer,Romana Höftberger,Peter Birner,Irene Slavc,Karin Dieckmann,Thomas Czech,Herbert Budka,Johannes A. Hainfellner +8 more
TL;DR: Assessment of Ki-67 index in intracranial ependymoma is useful for outcome prediction in the routine diagnostic setting as well as prognostic and predictive values of tumor cell proliferation rates using anti-Ki-67 antigen and Topo-IIα immunolabeling on tumor samples.
Journal ArticleDOI
Inter-laboratory comparison of neuropathological assessments of beta-amyloid protein: a study of the BrainNet Europe consortium.
Irina Alafuzoff,Maria Pikkarainen,Thomas Arzberger,Dietmar Rudolf Thal,Safa Al-Sarraj,Jeanne E. Bell,Istvan Bodi,Herbert Budka,Estibaliz Capetillo-Zarate,Isidro Ferrer,Ellen Gelpi,Stephen M. Gentleman,Giorgio Giaccone,Nikolaos Kavantzas,Andy King,Penelope Korkolopoulou,Gabor G. Kovacs,David Meyronet,Camelia M. Monoranu,Piero Parchi,Efstratios Patsouris,Wolfgang Roggendorf,Christine Stadelmann,Nathalie Streichenberger,Fabricio Tagliavini,Hans A. Kretzschmar +25 more
TL;DR: It is noteworthy that to reach reproducible results a dichotomized assessment of Aβ-immunoreactivity rather than quantification and assignment of various types of lesions should be applied, particularly when comparing results obtained by different neuropathologists.